Literature DB >> 23354355

[Prominent conjunctival tumor].

M Ranjbar1, M Müller, B Neppert, A Brüggemann.   

Abstract

The case of a 57-year-old woman with a rapidly growing unpigmented conjunctival tumor is presented. Despite the clinical appearance the histology surprisingly confirmed a malignant melanoma of the conjunctiva. Various phenotypes and the rareness of this disease complicate a clinical diagnosis. Therapeutically, a complete excision of the tumor including a safety margin, adjuvant topical chemotherapy and closely monitored follow-up are crucial.

Entities:  

Mesh:

Year:  2013        PMID: 23354355     DOI: 10.1007/s00347-012-2753-2

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  5 in total

Review 1.  Conjunctival melanoma: pitfalls and dilemmas in management.

Authors:  Yevgeniy Shildkrot; Matthew W Wilson
Journal:  Curr Opin Ophthalmol       Date:  2010-09       Impact factor: 3.761

2.  Diagnosis and management of conjunctival and corneal intraepithelial neoplasia using ultra high-resolution optical coherence tomography.

Authors:  Mohamed Abou Shousha; Carol L Karp; Victor L Perez; Rodrigo Hoffmann; Roberta Ventura; Victoria Chang; Sander R Dubovy; Jianhua Wang
Journal:  Ophthalmology       Date:  2011-04-20       Impact factor: 12.079

3.  Long-term follow-up of patients with conjunctival melanoma.

Authors:  Cornelia Werschnik; Peter K Lommatzsch
Journal:  Am J Clin Oncol       Date:  2002-06       Impact factor: 2.339

4.  Conjunctival Melanoma: A New Clinical and Therapeutical Approach.

Authors:  M Rodríguez-Martín; J Rodríguez-Martín; N Merino de Paz; P Contreras Ferrer; P Rocha Cabrera; B Rodríguez Martín; G Gordillo Santana; A Martín-Herrera; A Noda-Cabrera
Journal:  Case Rep Dermatol       Date:  2010-08-27

Review 5.  Tumors of the conjunctiva and cornea.

Authors:  Carol L Shields; Jerry A Shields
Journal:  Surv Ophthalmol       Date:  2004 Jan-Feb       Impact factor: 6.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.